Skip to content

The Evaluation of Clinical Pathways base on Chinese Medicine for Patients with Acute Myocardial Infarction: A Multi-centre, Randomized Controlled Trial

The Evaluation of Clinical Pathways base on Chinese Medicine for Patients with Acute Myocardial Infarction: A Multi-centre, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008356
Enrollment
Unknown
Registered
2016-04-24
Start date
2016-04-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Interventions

Pathway Group:Integrative therapy with AHA/ACC Guildline therapy and Chinese Medicine expert consensus therapy
Control Group:AHA/ACC Guildline therapy

Sponsors

2nd Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The first diagnosis must be consistent with acute myocardial infarction, including ST-segment elevation and non-ST segment elevation myocardial infarction; (2) Agreed to receive revascularization treatment; (3) Between the ages of 18-80 years old (4) Volunteered to participate in this study, and had signed an informed consent.

Exclusion criteria

Exclusion criteria: (1) Younger than 18 years of age or over 80 years of age; (2) Combine with cardiogenic shock; (3) Simultaneously with other diseases, it requires special handling thereby affect the patient during hospitalization path implementation; (4) Merger psychosis, cancer, severe liver, kidney, hematopoietic system, nervous system and other primary diseases; (5) Pregnant or lactating women; (6) Participate in other researchers.

Design outcomes

Primary

MeasureTime frame
NYHA Class;major adverse cardiac events, MACE;The number of days in hospital;Hospital costs;

Countries

China

Contacts

Public ContactLiheng Guo

2nd Affiliated Hospital of Guangzhou University of Chinese Medicine

guolh782@163.com+86 13798067825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026